EUVIMEDEUVIMED entdecken
Crossref

Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma

Kouki Imaoka, Masahiro Ohira, Minoru Hattori, Ichiya Chogahara, Saki Sato, Mayuna Nakamura, Tomoaki Bekki, Koki Sato, Yuki Imaoka, Ryosuke Nakano, Takuya Yano, Hiroshi Sakai und 6 weitere

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Kouki Imaoka und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Transplantation, Liver Neoplasms, Neutrophils. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Japan Science and Technology Agency, Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver TransplantationLiver NeoplasmsNeutrophilsLiving DonorsKiller Cells, NaturalImmunotherapyHumansMaleFemaleRetrospective StudiesMiddle AgedPrognosisLymphocytesAdult

Autor:innen und Institutionen

  • Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Division of Regeneration and Medicine, Medical Center for Translationa…
  • Advanced Medical Skills Training Center, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Förderung

  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Imaoka, K., Ohira, M., Hattori, M., Chogahara, I., Sato, S., Nakamura, M., Bekki, T., Sato, K., Imaoka, Y., Nakano, R., Yano, T., Sakai, H., Kuroda, S., Tahara, H., Ide, K., Kobayashi, T., Tanaka, Y., & Ohdan, H. (2024). Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.02.002

Vancouver

Imaoka K, Ohira M, Hattori M, Chogahara I, Sato S, Nakamura M, et al. Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.02.002

BibTeX
@article{Imaoka2024,
  author = {Imaoka, Kouki and Ohira, Masahiro and Hattori, Minoru and Chogahara, Ichiya and Sato, Saki and Nakamura, Mayuna and Bekki, Tomoaki and Sato, Koki and Imaoka, Yuki and Nakano, Ryosuke and Yano, Takuya and Sakai, Hiroshi and Kuroda, Shintaro and Tahara, Hiroyuki and Ide, Kentaro and Kobayashi, Tsuyoshi and Tanaka, Yuka and Ohdan, Hideki},
  title = {Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.02.002}
}
Kostenlos starten →